PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34013301-2	2021	Cross-reactive antibodies specifically recognized the sialic acid moiety on N-linked glycans of the Spike protein and do not neutralize in vitro SARS-CoV-2.	n-linked glycans	76-92	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	100-105	
32915505-0	2020	Structural characterization of the N-linked glycans in the receptor binding domain of the SARS-CoV-2 spike protein and their interactions with human lectins using NMR spectroscopy.	n-linked glycans	35-51	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	101-106	
33758835-2	2021	The abundance of N-linked glycans across the SARS-CoV-2 spike protein is a potential source of heterogeneity between the many different vaccine candidates under investigation.	n-linked glycans	17-33	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	56-61	
33292056-0	2022	Sensing the interactions between carbohydrate-binding agents and N-linked glycans of SARS-CoV-2 spike glycoprotein using molecular docking and simulation studies.	n-linked glycans	65-81	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	96-101	
33292056-2	2022	The homotrimeric transmembrane spike (S) glycoprotein of coronaviruses which facilitates virus entry into the host cells is covered with N-linked glycans having oligomannose and complex sugars.	n-linked glycans	137-153	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	31-36	
34213308-2	2021	The abundance of N-linked glycans across the SARS-CoV-2 spike protein is a potential source of heterogeneity among the many different vaccine candidates under investigation.	n-linked glycans	17-33	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	56-61